176 related articles for article (PubMed ID: 16391828)
41. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.
Haudenschild DR; Palmer SM; Moseley TA; You Z; Reddi AH
Cancer Res; 2004 Nov; 64(22):8276-84. PubMed ID: 15548695
[TBL] [Abstract][Full Text] [Related]
42. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP.
Koochekpour S; Lee TJ; Wang R; Sun Y; Delorme N; Hiraiwa M; Grabowski GA; Culig Z; Minokadeh A
J Cell Biochem; 2007 Jun; 101(3):631-41. PubMed ID: 17171640
[TBL] [Abstract][Full Text] [Related]
43. Molecular fingerprinting of BMP2- and BMP4-treated embryonic maxillary mesenchymal cells.
Mukhopadhyay P; Singh S; Greene RM; Pisano MM
Orthod Craniofac Res; 2006 May; 9(2):93-110. PubMed ID: 16764684
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.
Deng H; Ravikumar TS; Yang WL
Cancer Lett; 2009 Aug; 281(2):220-31. PubMed ID: 19321257
[TBL] [Abstract][Full Text] [Related]
45. [Transcriptional regulation of placental transforming growth factor-beta by calcitriol in prostate cancer cells is androgen-independent].
Nazarova NIu; Chikhirzhina GI; Tuohimaaa P
Mol Biol (Mosk); 2006; 40(1):84-9. PubMed ID: 16523695
[TBL] [Abstract][Full Text] [Related]
46. Biphasic effect of androgens on prostate cancer cells and its correlation with androgen receptor coactivator dopa decarboxylase.
Shao C; Wang Y; Yue HH; Zhang YT; Shi CH; Liu F; Bao TY; Yang ZY; Yuan JL; Shao GX
J Androl; 2007; 28(6):804-12. PubMed ID: 17581945
[TBL] [Abstract][Full Text] [Related]
47. Atlas of dihydrotestosterone actions on the transcriptome of prostate in vivo.
Ma C; Yoshioka M; Boivin A; Gan L; Takase Y; Labrie F; St-Amand J
Prostate; 2009 Feb; 69(3):293-316. PubMed ID: 19023869
[TBL] [Abstract][Full Text] [Related]
48. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
49. Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression.
Xu C; Graf LF; Fazli L; Coleman IM; Mauldin DE; Li D; Nelson PS; Gleave M; Plymate SR; Cox ME; Torok-Storb BJ; Knudsen BS
Prostate; 2007 Nov; 67(15):1621-9. PubMed ID: 17823924
[TBL] [Abstract][Full Text] [Related]
50. Analysis of gene expression during staurosporine-induced neuronal differentiation of human prostate cancer cells.
Shimizu T; Okayama A; Inoue T; Takeda K
Oncol Rep; 2005 Aug; 14(2):441-8. PubMed ID: 16012728
[TBL] [Abstract][Full Text] [Related]
51. Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer.
Ho LL; Kench JG; Handelsman DJ; Scheffer GL; Stricker PD; Grygiel JG; Sutherland RL; Henshall SM; Allen JD; Horvath LG
Prostate; 2008 Sep; 68(13):1421-9. PubMed ID: 18615486
[TBL] [Abstract][Full Text] [Related]
52. Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells.
Guzey M; Luo J; Getzenberg RH
J Cell Biochem; 2004 Oct; 93(2):271-85. PubMed ID: 15368355
[TBL] [Abstract][Full Text] [Related]
53. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells.
Ro TB; Holt RU; Brenne AT; Hjorth-Hansen H; Waage A; Hjertner O; Sundan A; Borset M
Oncogene; 2004 Apr; 23(17):3024-32. PubMed ID: 14691444
[TBL] [Abstract][Full Text] [Related]
54. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
[TBL] [Abstract][Full Text] [Related]
55. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
Lu S; Dong Z
Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
[TBL] [Abstract][Full Text] [Related]
56. Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.
Thelen P; Jarry H; Ringert RH; Wuttke W
Planta Med; 2004 May; 70(5):397-400. PubMed ID: 15124082
[TBL] [Abstract][Full Text] [Related]
57. Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells.
Bruckheimer EM; Kyprianou N
Prostate; 2002 Oct; 53(2):133-42. PubMed ID: 12242728
[TBL] [Abstract][Full Text] [Related]
58. BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells.
Wen XZ; Miyake S; Akiyama Y; Yuasa Y
Biochem Biophys Res Commun; 2004 Mar; 316(1):100-6. PubMed ID: 15003517
[TBL] [Abstract][Full Text] [Related]
59. Regulation of growth hormone receptors in human prostate cancer cell lines.
Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305
[TBL] [Abstract][Full Text] [Related]
60. Sex steroid hormone metabolism and prostate cancer.
Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
